Trial · NCT05637606
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Composite endpoint of postoperative mortality and at least one major organ dysfunction (see description in the secondary outcomes). | up to 30 days after operation | Composite postoperative outcome |
| Secondary | Hospital stay (days) | up to 30 days after operation | Hospital stay (days) |
| Secondary | ICU stay (days) | up to 30 days after operation | Intensive Care Unit stay (days) |
| Secondary | ICU readmission | up to 30 days after operation | Intensive Care Unit readmissions |
| Secondary | Sequential Organ Failure Assessment (SOFA) scores on postoperative | up to 7 days after operation | Postoperative organ failure - SOFA scores ranges from 0 (\<2% of mortality) to 24 (\>90% of mortality) |
| Secondary | Overall intraoperative fluid balance | day 1 after the operation | Intraoperative infusions (crystalloids, colloids, blood products) / Intraoperative loss balance (urine output) |
| Secondary | Mortality | up to 30 days after operation | Mortality |
| Secondary | Vasopressors use | day 1 after the operation | Dose and timing of vasoactive drug infusion intraoperatively |
| Secondary | Need for reoperation | day 30 after operation | Need of a new surgical treatment |
| Other | CARDIOVASCULAR complications | day 7 after operation | * Acute heart failure * Myocardial injury after non-cardiac surgery * Myocardial infarction * Bradycardia * Symptomatic proximal deep venous thrombosis * Peripheral arterial and venous thrombosis |
| Other | NEUROLOGICAL complications | day 7 after operation | * Stroke * Subarachnoid hemorrhage * Cerebral venous thrombosis * Seizure * Acute delirium |
| Other | RESPIRATORY | day 7 after operation | * Acute respiratory distress * Hypoxemia with or without acute respiratory distress * Need for invasive, non-invasive ventilation or high-flow nasal cannula for acute respiratory distress. * Acute respiratory distress syndrome. * Pulmonary edema * Pulmonary embolism |
| Other | RENAL | day 7 after operation | • Acute Kidney Injury (AKI) and AKI stages defined according to the AKIN classification/staging system of acute kidney injury |
| Other | SEPSIS and Septic shock | day 7 after operation | Based on the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) criteria, sepsis required a quick Sequential Organ Failure Assessment (qSOFA) Score ≥ 2 points due to infection, septic shock defined as indicated by the Surviving Sepsis Campaign Guidelines |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05637606/registered